Bioaerosol Sampling Device (BSD) Clinical Study

Status unconfirmed

Conditions studied: COVID-19

In brief

The goal of this clinical trial is to learn about the bioaerosol sampling device (BSD) and how it can sample patient bioaerosols (breath) and patient's nares for the detection of COVID-19 viral particles in patients seeking to be tested for COVID-19.

Key facts

Study ID
NCT06047067
Run by
Cantor BioConnect, Inc.
People needed
330
Starts
2023-07-10
Expected to finish
2024-05-19
Last updated by the study team
2023-09-21

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.